Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers. [electronic resource]
Producer: 20111207Description: 196-9 p. digitalISSN:- 1095-6859
- Adult
- Aged
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Fallopian Tube Neoplasms -- drug therapy
- Female
- Genes, BRCA1
- Genes, BRCA2
- Humans
- Middle Aged
- Mutation
- Ovarian Neoplasms -- drug therapy
- Peritoneal Neoplasms -- drug therapy
- Platinum -- therapeutic use
- Retrospective Studies
- Topoisomerase I Inhibitors -- therapeutic use
- Topotecan -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.